Sanofi SNY
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | 8.79B | 9.72B | -- | |
| Total Depreciation and Amortization | -- | 3.31B | 964.69M | -- | |
| Total Amortization of Deferred Charges | -- | 130.38M | -- | -- | |
| Total Other Non-Cash Items | -- | -2.08B | -2.46B | -- | |
| Change in Net Operating Assets | -- | 2.11B | 20.96M | -- | |
| Cash from Operations | -- | 12.26B | 8.25B | -- | |
| Capital Expenditure | -- | -2.02B | 28.89M | -- | |
| Sale of Property, Plant, and Equipment | -- | 971.15M | -14.84M | -- | |
| Cash Acquisitions | -- | -10.92B | 18.39M | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 8.88B | -636.13M | -- | |
| Cash from Investing | -- | -3.08B | -603.68M | -- | |
| Total Debt Issued | -- | 5.56B | 0.00 | -- | |
| Total Debt Repaid | -- | -4.06B | 0.00 | -- | |
| Issuance of Common Stock | -- | 4.21B | 4.03B | -- | |
| Repurchase of Common Stock | -- | -9.06B | -4.03B | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -10.97B | -5.42B | -- | |
| Other Financing Activities | -- | -86.00M | -5.64B | -- | |
| Cash from Financing | -- | -9.38B | -6.39B | -- | |
| Foreign Exchange rate Adjustments | -- | -51.90M | -60.04M | -- | |
| Miscellaneous Cash Flow Adjustments | -- | 201.20M | 201.20M | -- | |
| Net Change in Cash | -- | -58.43M | 1.40B | -- | |